Ovarian Cancer

Multiple trials are underway for individuals with ovarian cancer. For a more comprehensive list of Nexavar® (sorafenib) clinical trials, please visit clinicaltrials.gov or call 866-639-2827.

Phase 2 Study of Nexavar as Maintenance Therapy
Enrollment Complete
Study Design: Randomized, double-blind, placebo-controlled trial
Patients: Stage III or IV ovarian cancer patients who have achieved a clinical complete response (disappearance of all clinical and radiological evidence of tumor) after  one regimen of standard platinum-based chemotherapy
Purpose: To determine the effectiveness of Nexavar when compared to placebo as maintenance therapy for patients with advanced ovarian cancer in complete remission following surgery, by assessing the difference in progression-free survival (PFS), as well as to evaluate other measures of efficacy and safety
Location: Multiple centers throughout the United States, Canada, Europe and the Asia-Pacific region

Stock Quote (update every 15 minutes): As of 4:00pm - 5/20/2011

  • Symbol
    ONXX
  • Last
    43.71 +0.22
  • Open
    43.46
  • High
    43.81
  • Low
    42.49
  • Volume
    1139204